Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Adam Boxall"'
Autor:
Chaitanya Erady, Adam Boxall, Shraddha Puntambekar, N. Suhas Jagannathan, Ruchi Chauhan, David Chong, Narendra Meena, Apurv Kulkarni, Bhagyashri Kasabe, Kethaki Prathivadi Bhayankaram, Yagnesh Umrania, Adam Andreani, Jean Nel, Matthew T. Wayland, Cristina Pina, Kathryn S. Lilley, Sudhakaran Prabakaran
Publikováno v:
npj Genomic Medicine, Vol 6, Iss 1, Pp 1-17 (2021)
Abstract Uncharacterized and unannotated open-reading frames, which we refer to as novel open reading frames (nORFs), may sometimes encode peptides that remain unexplored for novel therapeutic opportunities. To our knowledge, no systematic identifica
Externí odkaz:
https://doaj.org/article/410f193223914d33badf65ab4ce92412
Autor:
Adam Andreani, Cristina Pina, Apurv Kulkarni, Matthew T. Wayland, Kathryn S. Lilley, Sudhakaran Prabakaran, N. Suhas Jagannathan, David Chong, Bhagyashri Kasabe, Chaitanya Erady, Kethaki Prathivadi Bhayankaram, Adam Boxall, Jean Henri Nel, Narendra Meena, Yagnesh Umrania, Ruchi Chauhan, Shraddha Puntambekar
Publikováno v:
NPJ Genomic Medicine
npj Genomic Medicine, Vol 6, Iss 1, Pp 1-17 (2021)
npj Genomic Medicine, Vol 6, Iss 1, Pp 1-17 (2021)
© The Author(s) 2021. Uncharacterized and unannotated open-reading frames, which we refer to as novel open reading frames (nORFs), may sometimes encode peptides that remain unexplored for novel therapeutic opportunities. To our knowledge, no systema
Autor:
Harpreet K Saini, Tomoko Smyth, George Ward, Matthew Davis, Simone Jueliger, John Lyons, Martin Sims, Jason A. Taylor, Adam Boxall, Andrea Biondo
Publikováno v:
Blood. 138:3986-3986
Introduction: Tolinapant is a potent, non-peptidomimetic antagonist of cIAP1, cIAP2 and XIAP. In ongoing Phase 2 trial (NCT02503423), tolinapant has shown activity against highly pre-treated peripheral and cutaneous T-cell lymphoma (Samaniego et al.,